FDA Inspection 1277419 — Avista Pharma Solutions, Inc.
The FDA completed an inspection of Avista Pharma Solutions, Inc. on July 3, 2025 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 3, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Durham, NC (United States)